Cara Therapeutics

Youtube Subscribe

Open: 2.88 Close: 2.79 Change: -0.09

9 things an AI found about Cara Therapeutics that you should know before investing.

This document will help you to evaluate Cara Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Cara Therapeutics are: Zacks, Cara, Therapeutics, CARA, Stock, Price, Today, …

Concept Map

Semantic Network

Stock Summary

Cara Therapeutics, Inc. focuses on developing and commercializing therapeutics treatment of pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the.

Today's Summary

Zacks: Cara Therapeutics - CARA - Stock Price Today - Zacks Is It Time to Buy CARA? Shares are down today. Cara Therapeutics (NASDAQ:CARA) is a favorite amongst institutional investors who own 67% of the companys shares. The company is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.

Today's News

Zacks: Cara Therapeutics - CARA - Stock Price Today - Zacks Is It Time to Buy CARA? Shares are down today. Cara Therapeutics (NASDAQ:CARA) is a favorite amongst institutional investors who own 67% of the companys shares. The company is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.

Stock Profile

"Cara Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. Its product candidate, including Oral KORSUVA (difelikefalin), which has completed Phase II clinical trial to treat pruritus atopic dermatitis and pruritus non-dialysis-dependent chronic kidney disease (NDD-CKD) associated pruritus; and in Phase II clinical trial to treat pruritus chronic liver disease (CLD) primary biliary cholangitis (PBC) and notalgia paresthetica. Cara Therapeutics, Inc. has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. and Winhealth Pharma for the co-development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis in China; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. The company was incorporated in 2004 and is based in Stamford, Connecticut."

Keywords

How much time have you spent trying to decide whether investing in Cara Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Cara Therapeutics are: Zacks, Cara, Therapeutics, CARA, Stock, Price, Today, and the most common words in the summary are: state, united, therapeutic, cara, market, inc, nasdaq, . One of the sentences in the summary was: Zacks: Cara Therapeutics - CARA - Stock Price Today - Zacks Is It Time to Buy CARA? Shares are down today. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #state #united #therapeutic #cara #market #inc #nasdaq.

Read more →

Youtube Subscribe

---